Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:38:12.524Z.
Consensus retrieved: 2026-10-06T15:34:12.713Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:38:12.524Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d00a9c235f8f3f2200d332a4911885706ef223ec632fccfa45bb3326c1a5dd06
Forward PE Ratio (N/A) = Dated Quote Price ($5.13) / Consensus Forward EPS ($-1.67)
FORWARD PE RATIO
N/A
PolyPid Ltd.
Market Cap
$97.90M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| PolyPid Ltd. (PYPD) | $97.90M | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | N/A |
| The Joint Corp. (JYNT)vs › | $101.36M | 29.63 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | 12.54 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 5.07 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $5.13, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.68 | $-3.04 – $-0.31 | 3 | n/m |
| 2027-12-31 | $-1.23 | $-1.50 – $-0.95 | 3 | n/m |
| 2028-12-31 | $-0.41 | $-0.44 – $-0.39 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
